ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL HEART, LUNG, AND BLOOD INSTITUTE

Deciphering Statin-Induced Muscle Symptoms: Mechanisms and Therapeutic Insights

Active
Institution
COLUMBIA UNIVERSITY HEALTH SCIENCES, NY
Principal investigator
Andrew Robert Marks
Funding
$654K
Duration
2025–2030
Open portfolio

Moonbase score

Still being scored

Abstract

Project Summary Statin therapy is widely prescribed for the management of cardiovascular diseases, yet statin-associated muscle symptoms (SAMSs) frequently lead to therapy discontinuation. Our study aims to elucidate the underlying mechanisms of SAMSs and explore potential therapeutic interventions. We hypothesize that statin-induced muscle weakness is mediated through ryanodine receptor 1 (RyR1) calcium leakage, exacerbated by the RyR1- T4706M mutation. We have access to muscle tissue and other samples from a patient who carries this RyR1- T4706M mutation and is profoundly intolerant of all statins. We further have a mouse model based on this patient’s genotype. Using cryo-electron microscopy, electrophysiological recordings, in vitro assays, and genetic mouse models, we will identify the binding sites of commonly used statins on RyR1, evaluate their effects on muscle function, and assess the potential benefits of RyR1 stabilization with ARM210 in preventing statin- induced muscle weakness. This research holds promise for identifying novel therapeutic strategies to mitigate SAMSs and improve patient tolerance of statin therapy.

LOADING MOONBASE SCORE

NATIONAL HEART, LUNG, AND BLOOD INSTITUTER01Therapeutic Development and Preclinical Studies Study Section[TDPS]weaknessstatinsmutationmuscleelectrophysiological recordingsmuscle weaknessstatininsights project

Questions for COLUMBIA UNIVERSITY HEALTH SCIENCES

Answered by the team behind this research.

Same researchers, same institution, same topic, scored first.